“…Additionally, the defined key role of CA inhibitor (CAI) molecules as antiglaucoma compounds and diuretics factor, it has recently appointed which they have capability as anticonvulsant, antiobesity, antiinfective, and anticancer drugs (Gulçin et al, ; Koçyiğit, Taşkıran, et al, ; Taslimi, Osmanova, et al, ; Taslimi, Caglayan, et al, ; Yamali, Gül, Ece, Taslimi, & Gulçin, ). Indeed, there are diverse approved compounds as AChEIs like galanthamine, donepezil, tacrine molecule, and rivastigmine for the treatment of AD (Bulut et al, ). Conforming to the cholinergic hypothesis, impairment of the cholinergic pathways plays a major role in the development of neurodegenerative diseases like depression, schizophrenia, AD problems with the regulation of traumatic brain injury and sleep (Huseynova et al, ; Taslimi, Sujayev, et al, ).…”